Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo

Immunity

Volumn 44, Issue 4, 2016, Pages 807-820

  Lee, Chang Sup ^a,b   Penberthy, Kristen K ^a,b   Wheeler, Karen M ^b   Juncadella, Ignacio J ^a,b   Vandenabeele, Peter ^c,d   Lysiak, Jeffrey J ^b   Ravichandran, Kodi S ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BAI1 PROTEIN; CYTOKINE; G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG; ANGIOGENIC PROTEIN; BAI1 PROTEIN, MOUSE; DEXTRAN SULFATE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ATTENUATION; BONE MARROW CELL; COLITIS; COLON MUCOSA; CONTROLLED STUDY; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INTESTINAL CLEARANCE; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLON; CYTOLOGY; EPITHELIUM CELL; GENETICS; HCT 116 CELL LINE; HUMAN; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; KNOCKOUT MOUSE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ANGIOGENIC PROTEINS; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; EPITHELIAL CELLS; HCT116 CELLS; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84962231834     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.02.005     Document Type: Article

References (65)

1. Arandjelovic S., Ravichandran K.S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 2015, 16:907-917.
2. Bagci H., Laurin M., Huber J., Muller W.J., Côté J.F. Impaired cell death and mammary gland involution in the absence of Dock1 and Rac1 signaling. Cell Death Dis. 2014, 5:e1375.
3. Bjerrum J.T., Hansen M., Olsen J., Nielsen O.H. Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis. Inflamm. Bowel Dis. 2010, 16:999-1007.
4. Brinkman B.M., Becker A., Ayiseh R.B., Hildebrand F., Raes J., Huys G., Vandenabeele P. Gut microbiota affects sensitivity to acute DSS-induced colitis independently of host genotype. Inflamm. Bowel Dis. 2013, 19:2560-2567.
5. Brugnera E., Haney L., Grimsley C., Lu M., Walk S.F., Tosello-Trampont A.C., Macara I.G., Madhani H., Fink G.R., Ravichandran K.S. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat. Cell Biol. 2002, 4:574-582.
6. Burczynski M.E., Peterson R.L., Twine N.C., Zuberek K.A., Brodeur B.J., Casciotti L., Maganti V., Reddy P.S., Strahs A., Immermann F., et al. Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J. Mol. Diagn. 2006, 8:51-61.
7. Carey R., Jurickova I., Ballard E., Bonkowski E., Han X., Xu H., Denson L.A. Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflamm. Bowel Dis. 2008, 14:446-457.
8. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999, 8:265-277.
9. Colombel J.F., Sandborn W.J., Reinisch W., Mantzaris G.J., Kornbluth A., Rachmilewitz D., Lichtiger S., D'Haens G., Diamond R.H., Broussard D.L., et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N. Engl. J. Med. 2010, 362:1383-1395. SONIC Study Group.
10. Costello C.M., Mah N., Häsler R., Rosenstiel P., Waetzig G.H., Hahn A., Lu T., Gurbuz Y., Nikolaus S., Albrecht M., et al. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med. 2005, 2:e199.
11. Dassopoulos T., Sultan S., Falck-Ytter Y.T., Inadomi J.M., Hanauer S.B. American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology 2013, 145. 1464-78.e1, 5.
12. Devitt A., Parker K.G., Ogden C.A., Oldreive C., Clay M.F., Melville L.A., Bellamy C.O., Lacy-Hulbert A., Gangloff S.C., Goyert S.M., Gregory C.D. Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. J. Cell Biol. 2004, 167:1161-1170.
13. Devkota S., Chang E.B. Nutrition, microbiomes, and intestinal inflammation. Curr. Opin. Gastroenterol. 2013, 29:603-607.
14. Di Sabatino A., Ciccocioppo R., Luinetti O., Ricevuti L., Morera R., Cifone M.G., Solcia E., Corazza G.R. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis. Colon Rectum 2003, 46:1498-1507.
15. Diehl G.E., Longman R.S., Zhang J.X., Breart B., Galan C., Cuesta A., Schwab S.R., Littman D.R. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature 2013, 494:116-120.
16. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., Elson C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994, 107:1643-1652.
17. Elliott M.R., Zheng S., Park D., Woodson R.I., Reardon M.A., Juncadella I.J., Kinchen J.M., Zhang J., Lysiak J.J., Ravichandran K.S. Unexpected requirement for ELMO1 in clearance of apoptotic germ cells in vivo. Nature 2010, 467:333-337.
18. Evans C.J., Aguilera R.J. DNase II: genes, enzymes and function. Gene 2003, 322:1-15.
19. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 1992, 148:2207-2216.
20. Gao Y., Li X., Yang M., Zhao Q., Liu X., Wang G., Lu X., Wu Q., Wu J., Yang Y., et al. Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model. Carcinogenesis 2013, 34:1861-1869.
21. Gregory C.D., Pound J.D. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J. Pathol. 2011, 223:177-194.
22. Gumienny T.L., Brugnera E., Tosello-Trampont A.C., Kinchen J.M., Haney L.B., Nishiwaki K., Walk S.F., Nemergut M.E., Macara I.G., Francis R., et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 2001, 107:27-41.
23. Günther C., Martini E., Wittkopf N., Amann K., Weigmann B., Neumann H., Waldner M.J., Hedrick S.M., Tenzer S., Neurath M.F., Becker C. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 2011, 477:335-339.
24. Hagiwara C., Tanaka M., Kudo H. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J. Gastroenterol. Hepatol. 2002, 17:758-764.
25. Hanayama R., Tanaka M., Miyasaka K., Aozasa K., Koike M., Uchiyama Y., Nagata S. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004, 304:1147-1150.
26. Henson P.M. Dampening inflammation. Nat. Immunol. 2005, 6:1179-1181.
27. Iwamoto M., Koji T., Makiyama K., Kobayashi N., Nakane P.K. Apoptosis of crypt epithelial cells in ulcerative colitis. J. Pathol. 1996, 180:152-159.
28. Juncadella I.J., Kadl A., Sharma A.K., Shim Y.M., Hochreiter-Hufford A., Borish L., Ravichandran K.S. Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature 2013, 493:547-551.
29. Kugathasan S., Baldassano R.N., Bradfield J.P., Sleiman P.M., Imielinski M., Guthery S.L., Cucchiara S., Kim C.E., Frackelton E.C., Annaiah K., et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat. Genet. 2008, 40:1211-1215.
30. Lacy-Hulbert A., Smith A.M., Tissire H., Barry M., Crowley D., Bronson R.T., Roes J.T., Savill J.S., Hynes R.O. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proc. Natl. Acad. Sci. USA 2007, 104:15823-15828.
31. Lakso M., Pichel J.G., Gorman J.R., Sauer B., Okamoto Y., Lee E., Alt F.W., Westphal H. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 1996, 93:5860-5865.
32. Lew E.D., Oh J., Burrola P.G., Lax I., Zagórska A., Través P.G., Schlessinger J., Lemke G. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. eLife 2014, 3:3.
33. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
34. Loo D.T. In situ detection of apoptosis by the TUNEL assay: an overview of techniques. Methods Mol. Biol. 2011, 682:3-13.
35. Madison B.B., Dunbar L., Qiao X.T., Braunstein K., Braunstein E., Gumucio D.L. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 2002, 277:33275-33283.
36. Miyanishi M., Tada K., Koike M., Uchiyama Y., Kitamura T., Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007, 450:435-439.
37. Monks J., Smith-Steinhart C., Kruk E.R., Fadok V.A., Henson P.M. Epithelial cells remove apoptotic epithelial cells during post-lactation involution of the mouse mammary gland. Biol. Reprod. 2008, 78:586-594.
38. Moussion C., Ortega N., Girard J.P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?. PLoS ONE 2008, 3:e3331.
39. Nagata S., Hanayama R., Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010, 140:619-630.
40. Nielsen O.H., Ainsworth M.A. Tumor necrosis factor inhibitors for inflammatory bowel disease. N. Engl. J. Med. 2013, 369:754-762.
41. Noble C.L., Abbas A.R., Cornelius J., Lees C.W., Ho G.T., Toy K., Modrusan Z., Pal N., Zhong F., Chalasani S., et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 2008, 57:1398-1405.
42. Owen K.A., Abshire M.Y., Tilghman R.W., Casanova J.E., Bouton A.H. FAK regulates intestinal epithelial cell survival and proliferation during mucosal wound healing. PLoS ONE 2011, 6:e23123.
43. Park D., Tosello-Trampont A.C., Elliott M.R., Lu M., Haney L.B., Ma Z., Klibanov A.L., Mandell J.W., Ravichandran K.S. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 2007, 450:430-434.
44. Park S.Y., Jung M.Y., Kim H.J., Lee S.J., Kim S.Y., Lee B.H., Kwon T.H., Park R.W., Kim I.S. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 2008, 15:192-201.
45. Park D., Han C.Z., Elliott M.R., Kinchen J.M., Trampont P.C., Das S., Collins S., Lysiak J.J., Hoehn K.L., Ravichandran K.S. Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein. Nature 2011, 477:220-224.
46. Pasparakis M., Vandenabeele P. Necroptosis and its role in inflammation. Nature 2015, 517:311-320.
47. Perše M., Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J. Biomed. Biotechnol. 2012, 2012:718617.
48. Peterson L.W., Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 2014, 14:141-153.
49. Poon I.K., Lucas C.D., Rossi A.G., Ravichandran K.S. Apoptotic cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 2014, 14:166-180.
50. Qiu W., Wu B., Wang X., Buchanan M.E., Regueiro M.D., Hartman D.J., Schoen R.E., Yu J., Zhang L. PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J. Clin. Invest. 2011, 121:1722-1732.
51. Ravichandran K.S., Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat. Rev. Immunol. 2007, 7:964-974.
52. Rothlin C.V., Carrera-Silva E.A., Bosurgi L., Ghosh S. TAM receptor signaling in immune homeostasis. Annu. Rev. Immunol. 2015, 33:355-391.
53. Sandahl M., Hunter D.M., Strunk K.E., Earp H.S., Cook R.S. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev. Biol. 2010, 10:122.
54. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:390-407.
55. Schmidt N., Gonzalez E., Visekruna A., Kühl A.A., Loddenkemper C., Mollenkopf H., Kaufmann S.H., Steinhoff U., Joeris T. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 2010, 59:896-906.
56. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001, 411:207-211.
57. Segawa K., Nagata S. An apoptotic 'eat me' signal: phosphatidylserine exposure. Trends Cell Biol. 2015, 25:639-650.
58. Spencer S.P., Belkaid Y. Dietary and commensal derived nutrients: shaping mucosal and systemic immunity. Curr. Opin. Immunol. 2012, 24:379-384.
59. Suwara M.I., Green N.J., Borthwick L.A., Mann J., Mayer-Barber K.D., Barron L., Corris P.A., Farrow S.N., Wynn T.A., Fisher A.J., Mann D.A. IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. Mucosal Immunol. 2014, 7:684-693.
60. Suzuki J., Umeda M., Sims P.J., Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010, 468:834-838.
61. Suzuki J., Denning D.P., Imanishi E., Horvitz H.R., Nagata S. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science 2013, 341:403-406.
62. Swan C., Duroudier N.P., Campbell E., Zaitoun A., Hastings M., Dukes G.E., Cox J., Kelly F.M., Wilde J., Lennon M.G., et al. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut 2013, 62:985-994.
63. Targownik L.E., Bernstein C.N. Infectious and malignant complications of TNF inhibitor therapy in IBD. Am. J. Gastroenterol. 2013, 108:1835-1842. quiz 1843.
64. Xiao C., Calado D.P., Galler G., Thai T.H., Patterson H.C., Wang J., Rajewsky N., Bender T.P., Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159.
65. Zagórska A., Través P.G., Lew E.D., Dransfield I., Lemke G. Diversification of TAM receptor tyrosine kinase function. Nat. Immunol. 2014, 15:920-928.